AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Divaldax 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Daxia Healthcare

Salt Composition

Divalproex (750mg)

Overview Divaldax 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release Divaldax 750mg tablet. It's also occasionally prescribed for bipolar disorder management, either independently or as adjunctive therapy. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer this medication consistently at the same time each day, with or without food, for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses can exacerbate the underlying condition and precipitate seizures. Abrupt cessation is contraindicated. Commonly reported adverse effects include headache, visual blurring, nausea, emesis, vertigo, fatigue, ataxia, ecchymosis, and hypothermia. While usually mild, persistent or bothersome side effects warrant medical consultation. Report any skin rash immediately. Prolonged use may contribute to osteoporosis and fracture risk. Suicidal ideation and behavior are rare but potential adverse events; report any mood changes promptly. Prior to commencing treatment, inform your physician of any pre-existing cardiac, hepatic, renal, or urinary dysfunction, depression, or suicidal tendencies. Potential drug interactions necessitate a comprehensive review of your current medication regimen. Consult your doctor before initiating or discontinuing Divaldax 750mg Tablet ER during pregnancy. Alcohol consumption should be minimized due to its potential to intensify side effects and seizure risk. Regular blood monitoring, pre- and post-treatment, may be necessary to ensure appropriate dosage.

Primary Ingredients of Divaldax 750mg Tablet ER

No text provided. Please provide the text you want me to rephrase.

Uses of Divaldax 750mg Tablet ER

Managing epileptic seizures and bipolar disorder; migraine prophylaxis.

Major Benefits of Divaldax 750mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 750mg Divaldax Extended-Release tablet whole; do not break, crush, or chew it. While this medication can be taken with or without food, consistent timing is recommended.

Common Side effects of Divaldax 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divaldax 750mg Tablet ER:

Administer Divaldax 750mg Extended-Release tablets precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is permissible, although consistent daily timing is recommended.

How Divaldax 750mg Tablet ER works:

Epileptic seizures are managed by the extended-release Divaldax 750mg tablet, an anticonvulsant that reduces hyperactive neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Divaldax 750mg extended-release tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Divaldax 750mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Divaldax 750mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Divaldax 750mg tablets may impair driving ability due to potential adverse effects.

KidneyKidneySAFE IF PRESCRIBED

Divaldax 750mg extended-release tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverUNSAFE

Extended-release Divaldax 750mg tablets are likely unsuitable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Divaldax 750mg Tablet ER :

Should you forget a Divaldax 750mg Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Divaldax 750mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Actions Anticonvulsant sodium channel blockers

FAQs on Divaldax 750mg Tablet ER

Always consult your doctor before discontinuing Divaldax 750mg Tablet ER. Withdrawal should be gradual, under medical supervision, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Divaldax 750mg Extended-Release tablets can act as a mood stabilizer in some cases, particularly for individuals experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these mood changes.
Divaldax 750mg ER tablets can cause weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor if weight gain is a concern.
Divaldax 750mg ER tablets can cause drowsiness. Refrain from driving or activities requiring alertness until you understand their effects on you.
Hair loss is a possible, though typically temporary and dose-related, side effect of Divaldax 750mg Tablet ER. Contact your doctor if this side effect concerns you or continues.
Divaldax 750mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting and regularly during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from alcohol while taking Divaldax 750mg Tablet ER. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Divaldax 750mg Tablet ER, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to help prevent unexpected bleeding or bruising. Liver function tests are also recommended before and, for high-risk patients or those with liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Divaldax 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Symptoms may also include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Divaldax 750mg Tablet ER
147
MRP 179
17% off